12.40
price down icon3.13%   -0.40
 
loading
Schlusskurs vom Vortag:
$12.80
Offen:
$12.76
24-Stunden-Volumen:
4.66M
Relative Volume:
1.55
Marktkapitalisierung:
$925.65M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-13.48
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
-16.39%
1M Leistung:
+2.86%
6M Leistung:
+22.65%
1J Leistung:
+117.54%
1-Tages-Spanne:
Value
$12.35
$12.91
1-Wochen-Bereich:
Value
$12.35
$14.86
52-Wochen-Spanne:
Value
$5.31
$17.43

CorMedix Inc Stock (CRMD) Company Profile

Name
Firmenname
CorMedix Inc
Name
Telefon
908-517-9500
Name
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-25
Name
Neueste SEC-Einreichungen
Name
CRMD's Discussions on Twitter

Vergleichen Sie CRMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRMD
CorMedix Inc
12.40 955.51M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-30 Herabstufung D. Boral Capital Buy → Hold
2025-06-30 Eingeleitet H.C. Wainwright Buy
2025-03-07 Eingeleitet Leerink Partners Outperform
2025-01-13 Eingeleitet D. Boral Capital Buy
2024-08-26 Eingeleitet Rodman & Renshaw Buy
2023-08-10 Eingeleitet RBC Capital Mkts Outperform
2021-02-17 Eingeleitet Needham Buy
2020-09-29 Eingeleitet JMP Securities Mkt Outperform
2020-09-21 Eingeleitet Truist Buy
2019-12-18 Eingeleitet B. Riley FBR Buy
2019-03-26 Bestätigt H.C. Wainwright Buy
2018-12-06 Eingeleitet ROTH Capital Buy
2017-09-25 Bestätigt H.C. Wainwright Buy
2017-08-10 Bestätigt Rodman & Renshaw Buy
2017-05-05 Bestätigt Rodman & Renshaw Buy
2016-11-11 Bestätigt FBR & Co. Outperform
2016-03-17 Bestätigt FBR Capital Outperform
2016-03-03 Eingeleitet FBR Capital Outperform
2015-11-16 Bestätigt ROTH Capital Neutral
2015-10-29 Bestätigt ROTH Capital Neutral
2015-05-06 Herabstufung ROTH Capital Buy → Neutral
2014-12-08 Bestätigt ROTH Capital Buy
2011-10-03 Herabstufung Maxim Group Buy → Hold
Alle ansehen

CorMedix Inc Aktie (CRMD) Neueste Nachrichten

pulisher
Sep 06, 2025

Is CorMedix Inc. backed by strong institutional buyingProduct Launch & Entry Point Confirmation Signals - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

When is the best time to exit CorMedix Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

CorMedix at Cantor Global Healthcare Conference: Strategic Growth and Diversification - Investing.com Australia

Sep 06, 2025
pulisher
Sep 06, 2025

Will CorMedix Inc. benefit from current market trendsWeekly Stock Report & AI Optimized Trading Strategy Guides - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Using RSI to spot recovery in CorMedix Inc.July 2025 WrapUp & Weekly Watchlist of Top Performers - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is CorMedix Inc. stock a smart retirement pickMarket Rally & Accurate Entry/Exit Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Real time pattern detection on CorMedix Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Can trapped investors hope for a rebound in CorMedix Inc.July 2025 WrapUp & Verified Chart Pattern Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Comparing CorMedix Inc. in custom built stock radars2025 Bull vs Bear & Short-Term Trading Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Deerfield Management Sells Melinta Therapeutics To CorMedix - citybiz

Sep 05, 2025
pulisher
Sep 05, 2025

Is CorMedix Inc. showing signs of accumulationJuly 2025 Outlook & Stock Portfolio Risk Management - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Cormedix Inc. shares fall 1.05% premarket after presenting at Cantor and Morgan Stanley conferences. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

How high can CorMedix Inc. stock goJuly 2025 Recap & Expert Curated Trade Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What the charts say about CorMedix Inc. todayWeekly Trend Recap & Daily Profit Maximizing Trade Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

CorMedix to Participate in Upcoming Investor Conferences - 富途牛牛

Sep 05, 2025
pulisher
Sep 05, 2025

Sentiment analysis tools applied to CorMedix Inc.2025 Dividend Review & Free Community Consensus Stock Picks - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Statistical indicators supporting CorMedix Inc.’s strengthProduct Launch & Comprehensive Market Scan Reports - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Institutional Confidence Rises as CorMedix Inc. (CRMD) Hits Profitability - MSN

Sep 04, 2025
pulisher
Sep 04, 2025

Analyzing CorMedix Inc. with multi timeframe charts2025 Key Highlights & Entry Point Confirmation Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

CorMedix Inc.’s volatility index tracking explainedBull Run & Free Long-Term Investment Growth Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-04 02:05:07 - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will CorMedix Inc. benefit from seasonality2025 Earnings Impact & Free High Return Stock Watch Alerts - خودرو بانک

Sep 04, 2025
pulisher
Sep 03, 2025

Will CorMedix Inc. benefit from AI trends2025 Sector Review & Momentum Based Trading Signals - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

CorMedix completes $300M acquisition of Melinta Therapeutics - NJBIZ

Sep 03, 2025
pulisher
Sep 03, 2025

Wall Street Analysts Think CorMedix (CRMD) Could Surge 32.04%: Read This Before Placing a Bet - sharewise.com

Sep 03, 2025
pulisher
Sep 03, 2025

Using portfolio simulators with CorMedix Inc. included2025 Biggest Moves & Low Risk High Win Rate Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Signal strength of CorMedix Inc. stock in tech scannersJuly 2025 Volume & Daily Stock Trend Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

CorMedix Inc. stock chart pattern explainedMarket Growth Review & Verified Technical Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using Bollinger Bands to evaluate CorMedix Inc.Day Trade & Community Consensus Stock Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

CorMedix Inc. stock momentum explainedJuly 2025 Spike Watch & Low Volatility Stock Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

CorMedix Inc. stock volume spike explainedShare Buyback & Capital Protection Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What makes CorMedix Inc. stock price move sharplyWeekly Trend Summary & Smart Money Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

What is the long term forecast for CorMedix Inc. stockJuly 2025 Catalysts & Accurate Entry/Exit Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Heatmap analysis for CorMedix Inc. and competitorsPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

CorMedix Shares Drop 1.28% as $380M Volume Ranks 291st in Market Activity, $300M Melinta Acquisition Fuels Growth - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Cormedix Inc. shares fall 1.85% after-hours following the completion of Melinta Therapeutics acquisition. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

CorMedix Completes Acquisition of Melinta Therapeutics - citybiz

Sep 02, 2025
pulisher
Sep 02, 2025

How CorMedix Inc. stock performs during market volatility2025 Price Action Summary & Low Drawdown Trading Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Support Test: Should you buy the dip on CorMedix Inc.2025 Big Picture & Weekly High Return Stock Opportunities - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Is DefenCath Sufficient to Support CorMedix's Long-Term Growth Path? - sharewise.com

Sep 02, 2025
pulisher
Sep 02, 2025

What’s the recovery path for long term holders of CorMedix Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - Newser

Sep 02, 2025

Finanzdaten der CorMedix Inc-Aktie (CRMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):